Navigation Links
Painkillers Linked to Still More Problems

Two recent studies have offered still more evidence of the dangers linked with certain painkillers including kidney problems// in addition to the heart concerns that was already raised with the drug marketed as Vioxx.

One report from Brigham and Women's Hospital, and Harvard Medical School, Boston, said that an analysis of 114 studies that involved over 116,000 people showed that rofecoxib commonly known as Vioxx "was associated with increased renal and (heart) arrhythmia risks."

The reason as to why the drug would cause kidney damage is still unclear. In September 2004 Merck & Co Inc. withdrew Vioxx from the market after a three-year study revealed that it doubled the risk of heart attack and strokes in patients taking it for at least 18 months.

Another report from the University of Newcastle, New South Wales, Australia, following a review of 23 studies confirms the findings of an increased risk of heart problems with Vioxx that could be found "during the first 30 days of treatment in contrast to the the original suggestion that the vascular risk was only seen after 18 months."

Merck, however, facing more than 11,500 product liability lawsuits from people with claims of problems from Vioxx, has said that it still believes the data confirm the increased heart risk begins only after the medicine had been taken for 18 months.

The Australian analysis also found that celecoxib commonly sold as Celebrex and marketed by Pfizer Inc. was not associated with heart problems at a dose no greater than 200 milligrams a day.

Its review has also raised serious questions about the safety of diclofenac, an older (analgesic) drug marketed more in Europe than the United States.

The report added, "In conclusion ... diclofenac seems to share this risk and, unlike celecoxib, it appears to be harmful at commonly used doses. We believe there are grounds for reviewing its regulatory status."

The research details hav e been published in this week's Journal of the American Medical Association.

David Graham, a physician who works for the U.S. Food and Drug Administration said, "What does this all mean? First, rofecoxib (Vioxx) increases the risk of acute myocardial infarction at low and high doses." There is no initial 18-month period of immunity from risk."

He added that Celebrex "also increases (heart) risk at doses higher than 200 mg/d ... several other NSAIDs (non-steroidal anti-inflammatory drugs) increase risk, including ... diclofenac and meloxicam ... indomethacin and probably ibuprofen," while studies agree that naproxen is "neutral" for heart attack risk.

Graham added that for most patients with arthritis or other conditions requiring chronic pain relief "naproxen appears to be the safest NSAID choice from a cardiovascular perspective." Naproxen is commonly known as Aleve and marketed by Bayer Corp.
NLA
'"/>




Related medicine news :

1. Painkillers Do Not Shorten Dying Patients Lives
2. Painkillers may protect against Alzheimers disease
3. Painkillers may raise miscarriage risk
4. Painkillers Increase Risk of Miscarriage
5. In The Habit Of Taking Painkillers For Your Chronic Headache? Time To Switch Over
6. Aspirin Might Counter Side Effects of Cox-2 Painkillers
7. Painkillers Lead To Liver Failure
8. Study Advocates Use Of Oral Painkillers After Cesarean Section
9. Overdose of Opioid Painkillers Can Kill Pain and The Patient
10. UK Recommendations On Painkillers Flaunted
11. Painkillers—New and Old—Increase the Risk for Heart Attak
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/12/2018)... Fla. (PRWEB) , ... September 13, 2018 , ... Glori ... itself among the industry leaders. , The expo will include vendors, presentations, panel discussions ... be available to educate attendees on their award winning products and assist customers with ...
(Date:9/7/2018)... , ... September 07, 2018 , ... Start your engines ... 12 different sports experiences from which to choose. Pedal power is the name of ... Drag Strip Experience or turning left on the miniature Indianapolis Motor Speedway oval. , ...
(Date:9/7/2018)... Mont. (PRWEB) , ... September 07, 2018 , ... The ... Montana, is launching its first-ever national retreat for moms who are living without a ... slated for the weekend of October 26, 27 and 28 at Fairmont Hot ...
(Date:9/2/2018)... ... September 01, 2018 , ... ... Elite to its leading menu of results-driven aesthetic treatments. HydraFacial is a ... of clinically-proven ingredients to dramatically improve your skin’s tone and texture for ...
(Date:9/1/2018)... ... August 31, 2018 , ... “Vitamin D is the Key: ... Effect, debuted as a hot new release in Vitamins and Supplements, Medical Atlases, Vitamins, ... currently on a media tour around the United States. , With all the medical ...
Breaking Medicine News(10 mins):
(Date:9/15/2018)... ... September 14, 2018 , ... ... to enable greater library coverage. However, severe gaps and limitations associated with ... , Multiplexed phage display provides a simple, robust, and seamless high-throughput-ready version ...
(Date:9/13/2018)... (PRWEB) , ... September 13, 2018 , ... Dr. Rod ... Annual Dallas Rhinoplasty Meeting. The Meeting, which draws rhinoplasty experts from around the world, ... wide range of topics from the fundamentals of nasal anatomy to complex surgical procedures ...
(Date:9/12/2018)... (PRWEB) , ... September 12, 2018 , ... ... a line of Express Surveys as part of its Population Engage patient experience ... gain prompt feedback from patients, giving the provider organization a wealth of strategic ...
Breaking Medicine Technology: